News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
Rear Admiral Richard Childs has been selected as NHLBI’s Scientific Director of the Division of Intramural Research – National Heart, Lung, and Blood Institute
Photo taken from National Heart, Lung, and Blood Institute/LinkedIn
Mar 2, 2024, 19:27

Rear Admiral Richard Childs has been selected as NHLBI’s Scientific Director of the Division of Intramural Research – National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute shared a post on LinkedIn: 

“Rear Admiral Richard Childs has been selected as NHLBI‘s Scientific Director of the Division of Intramural Research.”

Additional information.

Source: National Heart, Lung, and Blood Institute/LinkedIn

cancer Intramural Research NHLBI NIH OncoDaily Oncology Richard Childs
Special Coverage
Blog
Aug 31, 2024, 14:07
Lisa Lacasse and Richard Deming about advocacy in Iowa and at the federal level
Blog
Aug 31, 2024, 14:04
IARC is leading the European Commission Initiative on Cervical Cancer
Blog
Aug 31, 2024, 14:02
Dégi László Csaba: Bridging the gap in Cancer Survivorship care
Insight
Aug 31, 2024, 13:58
Psycho-Oncology Research on Annals of Research in Oncology
Insight
Aug 31, 2024, 12:58
Eric Singhi: Our editorial in ASCO Daily News on the CHOICE-01 study
Blog
Aug 31, 2024, 12:55
Simple steps you can follow to reduce your cancer risk at any age by Arif Kamal - ACS
Insight
Aug 31, 2024, 12:49
New Insights on Psilocybin's Impact on the Human Brain by Joshua Siegel et al.
Blog
Aug 31, 2024, 12:46
Honoring Steve Abbott, Executive Director of Cincinnati Cancer Advisors
Blog
Aug 31, 2024, 11:09
Edward D. Esplin: Clinician Responses to Germline Genetic Testing in Prostate Cancer Management
Blog
Aug 31, 2024, 10:53
OncoInfluencers to Follow on Social Media: Dr. Fabio Ynoe de Moraes
Insight
Aug 31, 2024, 10:03
Myeloma Paper of the Day, August 31st, suggested by Robert Orlowski
Insight
Aug 31, 2024, 09:52
Article of the day, August 31st, suggested by the Immune Oncology Research Institute